Etiracetam

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Etiracetam
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • US: Unscheduled
Identifiers
  • (RS)-2-(2-Oxopyrrolidin-1-yl)butanamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
E number{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC8H14N2O2
Molar mass170.212 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • CCC(C(=O)N)N1CCCC1=O
  • InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) checkY
  • Key:HPHUVLMMVZITSG-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Etiracetam is a chemical compound belonging to the racetam family, which was developed as a nootropic drug. It is racemic; its biologically active enantiomeric form is levetiracetam, now marketed as an antiepileptic drug.[1]

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).